Ads
related to: breast cancer clinical trials namespfizerclinicaltrials.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Buparlisib was under investigation as a treatment for advanced or metastatic HER2-negative breast cancer in several phase III clinical trials: . The phase III trial BELLE-2 compared buparlisib + fulvestrant with fulvestrant alone in patients with advanced or metastatic HER2-negative, hormone receptor-positive (HR+) aromatase inhibitor-resistant breast cancer.
The Alliance seeks to reduce the impact of cancer on people by uniting a broad community of scientists and clinicians from many disciplines, committed to discovering, validating and disseminating effective strategies for the prevention and treatment of cancer. The Alliance conducts trials in the following disease and modality areas: breast ...
Ribociclib (LEE011, trade names Kisqali and Kryxana), is US FDA approved in combination with letrozole for treatment of breast cancer in patients with HR-positive, HER2-negative advanced metastatic breast cancer. [16] A phase three clinical trial found that ribociclib administered in combination with letrozole increased the likelihood of ...
The FDA approved trastuzumab deruxtecan for the treatment of HER2-low breast cancer based on DESTINY-Breast04, a randomized, multicenter, open label clinical trial that enrolled 557 adult participants with unresectable or metastatic HER2-low breast cancer. [15] The trial included two cohorts: 494 hormone receptor positive (HR+) participants and ...
A number of early phase clinical trials of gedatolisib for treatment of endometrial cancer, colorectal cancer, acute myeloid leukemia have been conducted. [8] [9] [10] Current clinical trials are focused on breast cancer, [11] [12] [13] [14]
In pancreatic cancer. Dinaciclib inhibits pancreatic cancer growth and progression in murine xenograft models. [8] In osteosarcoma Dinacliclib induces the apoptosis of osteosarcoma cells. [9] Apoptosis of osteosarcoma cultures can be induced by the combination of the cyclin-dependent kinase inhibitor SCH727965 and a heat shock protein 90 ...
Medical research for cancer begins much like research for any disease. In organized studies of new treatments for cancer, the pre-clinical development of drugs, devices, and techniques begins in laboratories, either with isolated cells or in small animals, most commonly rats or mice. In other cases, the proposed treatment for cancer is already ...
Results of a phase III clinical trial in triple-negative breast cancer were reported in October 2019. [89] Results of a phase II clinical trial in Merkel-cell carcinoma were reported in June 2016. [90] Results of a clinical trial in people with untreatable metastases arising from various solid tumors were reported in 2017. [91]
Ads
related to: breast cancer clinical trials namespfizerclinicaltrials.com has been visited by 10K+ users in the past month